Hinge Health initiated with an Outperform at Citizens JMP

Citizens JMP initiated coverage of Hinge Health (HNGE) with an Outperform rating and $58 price target The firm says the company offers a “differentiated and cost-effective approach” to the maintenance of musculoskeletal disorders. Channel checks indicate Hinge has established a “competitive moat” in the U.S. that leads to sticky relationships with key stakeholders, such as large national health plans in the U.S., the analyst tells investors in a research note.